Division of Breast Imaging and Breast Interventional Radiology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Shizuoka Prefecture, 411-8777, Japan.
Division of Pathology, Shizuoka Cancer Center Hospital, Shizuoka, 411-8777, Japan.
Eur Radiol. 2020 Jun;30(6):3363-3370. doi: 10.1007/s00330-020-06662-7. Epub 2020 Feb 15.
Given that a pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) is an important prognostic factor, evaluating pretreatment imaging findings is important. Outcomes for triple negative breast cancer (TNBC) vary with the histological classification, indicating that this classification is clinically significant. In this study, we focus on the most common histological subtype of TNBC, invasive carcinoma of no special type (NST), to evaluate whether intramammary edema (intra-E) and intratumoral necrosis (intra-N) on T2-weighted magnetic resonance imaging (T2WI) is a useful predictor of pCR.
We retrospectively included patients with biopsy-diagnosed TNBC-NST who received NAC between January 2014 and December 2017. Intra-E and intra-N were evaluated on T2WI before NAC. We grouped intra-E into no edema, peritumoral edema, prepectoral edema, and subcutaneous edema, and we defined intra-N as water-like signal intensity without enhancement on T2WI. We also evaluated tumor size, Ki-67 expression, and histological/nuclear grade, as well as their correlation with intra-E and intra-N.
Fifty-seven patients with TNBC-NST were enrolled. There was no correlation with the rate of pCR and the presence of either intra-E or intra-N before NAC. Only intra-E and tumor size showed a positive correlation.
In patients with TNBC-NST, intra-E and intra-N did not correlate with pCR, but intra-E did positively correlate with tumor size. NST may exhibit a greater response to NAC, regardless of whether intra-E or intra-N is present or not on the pretreatment MRI.
• Pathological complete response in TNBC-NST had no correlation with intramammary edema or intratumoral necrosis. • NAC may be justified in TNBC-NST even in the presence of edema or necrosis. • The extension of edema correlated with tumor size of TNBC-NST.
鉴于新辅助化疗(NAC)后病理完全缓解(pCR)是一个重要的预后因素,因此评估预处理的影像学表现很重要。三阴性乳腺癌(TNBC)的预后因组织学分类而异,这表明这种分类具有临床意义。在本研究中,我们专注于 TNBC 最常见的组织学亚型,即非特殊型浸润性乳腺癌(NST),以评估 T2 加权磁共振成像(T2WI)上的乳腺内水肿(intra-E)和肿瘤内坏死(intra-N)是否是 pCR 的有用预测指标。
我们回顾性纳入了 2014 年 1 月至 2017 年 12 月期间接受 NAC 的经活检诊断为 TNBC-NST 的患者。在 NAC 前评估 T2WI 上的 intra-E 和 intra-N。我们将 intra-E 分为无水肿、瘤周水肿、前胸壁水肿和皮下水肿,并将 intra-N 定义为 T2WI 上无增强的水样信号强度。我们还评估了肿瘤大小、Ki-67 表达、组织学/核分级,以及它们与 intra-E 和 intra-N 的相关性。
共纳入 57 例 TNBC-NST 患者。NAC 前 intra-E 和 intra-N 的存在与 pCR 率均无相关性。只有 intra-E 与肿瘤大小呈正相关。
在 TNBC-NST 患者中,intra-E 和 intra-N 与 pCR 无关,但 intra-E 与肿瘤大小呈正相关。NST 可能对 NAC 有更大的反应,无论预处理 MRI 上是否存在 intra-E 或 intra-N。
TNBC-NST 的 pCR 与乳腺内水肿或肿瘤内坏死无关。
即使存在水肿或坏死,也有理由对 TNBC-NST 进行 NAC。
水肿的范围与 TNBC-NST 的肿瘤大小相关。